Skip to main content

Advertisement

Fig. 1 | Chinese Journal of Cancer

Fig. 1

From: Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis

Fig. 1

Kaplan–Meier estimates of the survival of patients with the ascending type of nasopharyngeal carcinoma (NPC) treated with neoadjuvant chemotherapy plus subsequent radiotherapy (NACT + RT) or with concurrent chemoradiotherapy (CCRT). a Overall survival; b locoregional failure-free survival; c distant failure-free survival; d failure-free survival

Back to article page